Mousavi announced that Kimia Group has produced
the leading ingredient of acetaminophen and is among the top five countries in
the world in the production of this product, with the potential to compete in
global markets.
Speaking at the 14th Iran Petrochemical Forum,
Mousavi highlighted the necessity of downstream companies establishing chains
in the pharmaceutical sector to complete the value chain.
He said that as we move away from selling raw
products and focus on higher added-value production, the GDP will increase.
Mousavi added that Kimia Group is completing the
pharmaceutical value chain by building a factory to produce acetaminophen
products and adding codeine to the final acetaminophen product, which adds 100
times more value.
He stated that Kimia Group produces the metformin
pharmaceutical group and provides it to pharmaceutical companies and factories,
adding that acquiring the metformin production chain is also on their agenda.